David Dodwell is a Consultant in Clinical Oncology, with a special interest in the management of breast cancer, and works at Oxford University Hospitals NHS Trust. He is a senior research fellow within the Early Breast Cancer Triallists’ Collaborative Group (EBCTCG) in the Nuffield Department of Population Health, University of Oxford.
He is a member of several professional organisations and involved in many ongoing clinical trials and national breast cancer audits.
His research interests include adjuvant cytotoxic, endocrine and radio therapeutic interventions in breast cancer. He is chair of the British Breast Group.